Florida

Showing 11-20 of 27 grants

Title	Institution	Researcher	Program	Duration	Total Award Amount
Evaluation of the safety, tolerability, and general response to Lactobacillus johnsonii N6.2 in children and adolescents with T1D	University of Florida	Graciela Lorca	Cures	01-September-2019 to 31-August-2026	$355.941,78
NIICHE: A Human 3‑D Pancreatic Hydrogel Platform for Real‑Time Investigation of β‑Cell Immunogenicity and Therapeutic Screening in Type 1 Diabetes	University of Florida	Cherie Stabler	Cures	01-October-2026 to 30-September-2027	$300.000,00
Cord Blood Proteomic Markers of Type 1 Diabetes Risk: Towards Validation in a Diverse Birth Cohort	University of Florida	Angelica Ahrens	Cures	01-April-2026 to 31-March-2027	$199.235,28
Understanding Early Histopathological Changes in the Pancreas of those at Risk for Type 1 Diabetes Development	University of Florida	Alexandra Rippa	Cures	01-March-2026 to 28-February-2029	$237.690,00
mIL-2/CD25 fusion protein and BTK inhibitor combination therapy for T1D	University of Miami	Wasif Khan	Cures	01-May-2023 to 30-April-2027	$974.996,00
Low-dose IL-2 and anti-CD40L as a therapy for type 1 diabetes	University of Miami	Thomas Malek	Cures	01-June-2024 to 31-May-2027	$927.000,00
CD40L-Targeting Small Molecules as Novel Immunotherapies in Islet Cell Transplantation and T1D Prevention	University of Miami	Peter Buchwald	Cures	01-October-2026 to 30-September-2027	$250.000,00
Enhance β-Cell Replacement Therapies via Localized Immune Modulation Using DIANA Nanocarriers	University of Miami	Peter Buchwald	Cures	01-September-2023 to 31-August-2026	$900.000,00
bifunctional RNA therapeutics for T1D	University of Miami	Paolo Serafini	Cures	01-February-2025 to 31-January-2028	$900.000,00
Modulate beta cell proliferation and immunogenicity via aptamer-decorated lipid nanoparticles	University of Miami	Paolo Serafini	Cures	01-April-2023 to 31-March-2027	$894.602,00